Related Experiment Video
Updated: Jun 6, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
Hotspots and future trends of dermatofibrosarcoma protuberans
Zhen Meng1,2, Rui Zhang1, Zhihong Sun2
1Department of Plastic and Aesthetic Surgery, Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China.
Frontiers in Oncology
|November 27, 2024
Summary
This bibliometric analysis of Dermatofibrosarcoma protuberans (DFSP) research reveals key global trends and hotspots. Future DFSP research focuses on diagnosis, gene fusions, treatments, and immunotherapy.
Area of Science:
- Oncology
- Dermatology
- Bibliometrics
Background:
- Dermatofibrosarcoma protuberans (DFSP) is a soft tissue sarcoma with significant patient impact due to its infiltrative growth and high recurrence.
- Challenges in DFSP management include extensive surgical requirements and associated patient dysfunction, aesthetic concerns, and economic burdens.
Purpose of the Study:
- To analyze the global publication landscape of Dermatofibrosarcoma protuberans (DFSP) over 32 years.
- To identify research hotspots and emerging trends in DFSP through bibliometric analysis.
- To provide insights for future research directions and clinical decision-making in DFSP.
Main Methods:
- Bibliometric analysis of 1588 DFSP-related publications from 1990-2022.
- Utilized Web of Science Core Collection (WoSCC) database.
- Included analysis of collaborative networks, journal co-citations, reference co-citations, and keyword clustering.
Main Results:
- The United States and China are the leading countries in DFSP research output.
- A highly cited paper focused on Imatinib Mesylate treatment for advanced DFSP.
- Key research areas include diagnosis, COL1A1-PDGFB fusion gene, drug and surgical treatments, fibrosarcomatous transformation, and immunotherapy.
Conclusions:
- DFSP research faces ongoing clinical challenges.
- This bibliometric study offers valuable insights into the evolution and future trajectory of DFSP research.

